Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children
A pragmatic, mixed-method trial is to show the ability of OtoSight to change management of the pediatric patient presenting with ear pain in a way that improves patient outcomes and reduces costs.
- EligibilityCriteria: Inclusion Criteria:  Pediatric subjects between 6 months and 17 years of age Pediatric subjects presenting for an office visit with ear-related pain (otalgia)/otic complaints/earache indicative of potential Otitis Media with Effusion (OME) or Acute Otitis Media (AOM) Pediatric subjects where otoscopy would traditionally be indicated Pediatric subjects whose parents or legally authorized representative (LAR) have signed an informed consent  Exclusion Criteria:  The parent or guardian who attends visits does not speak the same language as their physician Pediatric subjects enrolled in another clinical trial Pediatric subjects with: Signs of severe chronic illness (e.g., immunodeficiency, congenital heart disease, encephalopathy, pulmonary disease other than asthma, and disorder of the ear, nose and throat) or any clinically significant illness or condition that, in the opinion of the investigator, would prohibit the subject from participating in the trial Anatomical conditions that would affect their ability to undergo an otoscopy. - HealthyVolunteers: Accepts Healthy Volunteers - Gender: All - MinimumAge: 6 Months - MaximumAge: 17 Years - StdAgeList: Child - StudyPopulation: Any pediatric patient between 6 months and 17 years of age scheduled for an office visit with ear-related complaints, deemed suitable for otoscopy assessment. - SamplingMethod: Non-Probability Sample